Drug
Bevacizumab Injection [Avastin]
Bevacizumab Injection [Avastin] is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_3
1
20%
Ph phase_4
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Other(3)
Detailed Status
unknown3
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)
Trials by Status
unknown360%
recruiting120%
completed120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingphase_4
Aflibercept and Bevacizumab for Diabetic Maculopathies
NCT06850571
completednot_applicable
IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes
NCT06559488
unknownphase_4
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
NCT03211741
unknownphase_3
Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer
NCT03950154
unknownphase_4
Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
NCT05514925
Clinical Trials (5)
Showing 5 of 5 trials
NCT06850571Phase 4
Aflibercept and Bevacizumab for Diabetic Maculopathies
NCT06559488Not Applicable
IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes
NCT03211741Phase 4
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
NCT03950154Phase 3
Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer
NCT05514925Phase 4
Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5